Wednesday, March 22, 2006


The University eBulletin reports the CAFE trial (part of the larger ASCOT trial), which has been looking at the use of an amlodipine based calcium channel blocker, and how it reduces blood pressure near the heart. It is more effective than the usual atenolol based treatment.

The trial has involved researchers from the Department of Cardiovascular Sciences.

Read the eBulletin.

No comments: